AMY S. BROIDRICK
CIK 1822917 · President/CSO · last filed 2022-08-04
AMY S. BROIDRICK is a President/CSO who has filed 6 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for QLGN, was dated Aug 4, 2022. Across all open-market trades the lifetime net is +$27.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
6
$27.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics, Inc. (QLGN) Delisted | President/CSO | 34,500 | $3.21 | $110.7K | $27.7K | 6 | 2022-08-04 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-04 | Qualigen Therapeutics, Inc. (QLGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | Qualigen Therapeutics, Inc. (QLGN) Delisted | Buy (P) | +30,000 | $18.6K | EDGAR |
| 2021-12-10 | Qualigen Therapeutics, Inc. (QLGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-26 | Qualigen Therapeutics, Inc. (QLGN) Delisted | Buy (P) | +4,500 | $9.1K | EDGAR |
| 2020-12-29 | Qualigen Therapeutics, Inc. (QLGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-28 | Qualigen Therapeutics, Inc. (QLGN) Delisted | Grant (A) | — | $0 | EDGAR |